Ten-Year Survival of Patients with Locally Advanced, Stage IB-IIB Cervical Cancer after Neoadjuvant Chemotherapy and Radical Hysterectomy

By Hwang Y.Y.   Moon H.   Cho S.H.   Kim K.T.   Moon Y.J.   Kim S.R.   Kim D.S.  

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 88-93

Elsevier

Access to resources Recommend Favorite

Impact on Survival Following Successful Neoadjuvant Chemotherapy and Radical Surgery for Stage IIb Bulky and Stage IIIb Cervical Cancer

By Sugiyama T.   Hasuo Y.   Nishida T.   Kamura T.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 330-331

Elsevier

Access to resources Recommend Favorite

Determinants of Response to a Cisplatin-Based Regimen as Neoadjuvant Chemotherapy in Stage IB-IIB Invasive Cervical Cancer

By Bolis G.   van Zainten-Przybysz I.   Scarfone G.   Zanaboni F.   Scarabelli C.   Tateo S.   Calabrese M.   Parazzini F.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 62-65

Academic Press

Access to resources Recommend Favorite

Prognostic Factors in Patients with Bulky Stage IB or IIA Cervical Carcinoma Undergoing Neoadjuvant Chemotherapy and Radical Hysterectomy

By Lai C.-H.   Hsueh S.   Chang T.-C.   Tseng C.-J.   Huang K.-G.   Chou H.-H.   Chen S.-M.   Chang M.-F.   Shum H.-C.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 456-462

Elsevier

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Stage IB2 Squamous Cell Carcinoma of the Cervix

By Serur E.   Mathews R.P.   Gates J.   Levine P.   Maiman M.   Remy J.C.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 348-356

Elsevier

Access to resources Recommend Favorite